These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8630098)

  • 1. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase.
    Xiong X; Smith JL; Kim C; Huang ES; Chen MS
    Biochem Pharmacol; 1996 Jun; 51(11):1563-7. PubMed ID: 8630098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation.
    Xiong X; Smith JL; Chen MS
    Antimicrob Agents Chemother; 1997 Mar; 41(3):594-9. PubMed ID: 9055999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand.
    Magee WC; Aldern KA; Hostetler KY; Evans DH
    Antimicrob Agents Chemother; 2008 Feb; 52(2):586-97. PubMed ID: 18056278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.
    Chamberlain JM; Sortino K; Sethna P; Bae A; Lanier R; Bambara RA; Dewhurst S
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate.
    Magee WC; Hostetler KY; Evans DH
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3153-62. PubMed ID: 16048917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
    Neyts J; Snoeck R; Balzarini J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells.
    Cihlar T; Chen MS
    Mol Pharmacol; 1996 Dec; 50(6):1502-10. PubMed ID: 8967971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
    Cihlar T; Fuller MD; Mulato AS; Cherrington JM
    Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system.
    Moore MR; Hamzeh FM; Lee FE; Lietman PS
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2404-8. PubMed ID: 7840578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC).
    Lalezari JP; Stagg RJ; Jaffe HS; Hitchcock MJ; Drew WL
    Adv Exp Med Biol; 1996; 394():105-15. PubMed ID: 8815677
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
    Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
    Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.
    Stals FS; de Clercq E; Bruggeman CA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2262-6. PubMed ID: 1666493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Takahashi K
    Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir.
    Kinchington PR; Araullo-Cruz T; Vergnes JP; Yates K; Gordon YJ
    Antiviral Res; 2002 Oct; 56(1):73-84. PubMed ID: 12323401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs.
    Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD
    Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
    Aldern KA; Ciesla SL; Winegarden KL; Hostetler KY
    Mol Pharmacol; 2003 Mar; 63(3):678-81. PubMed ID: 12606777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir.
    Harada K; Eizuru Y; Isashiki Y; Ihara S; Minamishima Y
    Arch Virol; 1997; 142(2):215-25. PubMed ID: 9125039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases beta and gamma.
    Cherrington JM; Allen SJ; McKee BH; Chen MS
    Biochem Pharmacol; 1994 Nov; 48(10):1986-8. PubMed ID: 7986213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
    Williams-Aziz SL; Hartline CB; Harden EA; Daily SL; Prichard MN; Kushner NL; Beadle JR; Wan WB; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3724-33. PubMed ID: 16127046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.